This Avenir Award Program grant supports early stage investigators (ESIs) conducting highly innovative research at the nexus of substance abuse and HIV/AIDS. The core purpose is to fund creative individuals developing basic and clinical approaches benefiting substance-using populations with or at risk for HIV/AIDS. A clear aim is to reduce HIV incidence, improve therapies, mitigate comorbid conditions, and ultimately advance HIV eradication. Proposals must explicitly describe the drug abuse connection. This future-oriented program fosters studies aligned with NIH HIV/AIDS Research Priorities, driving breakthroughs in this critical field.
Opportunity ID: 346749
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-23-125 |
| Funding Opportunity Title: | Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 10, 2023 |
| Last Updated Date: | Mar 10, 2023 |
| Original Closing Date for Applications: | Aug 15, 2025 |
| Current Closing Date for Applications: | Aug 15, 2025 |
| Archive Date: | Sep 20, 2025 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Independent school districts For profit organizations other than small businesses Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) State governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Native American tribal governments (Federally recognized) Small businesses Public housing authorities/Indian housing authorities Private institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Avenir means future in French, and the Avenir Award Program for Research on Substance Abuse and HIV/AIDS looks toward the future by supporting early stage investigators (ESI) proposing highly innovative studies that address NIH HIV/AIDS Research Priorities https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-137.html. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. The nexus with drug abuse should be clearly described. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support research approaches, both basic and clinical, which have the potential to benefit substance using populations with or at risk for HIV/AIDS by reducing HIV incidence, improving therapies for HIV, reducing the impact of comorbid conditions, and ultimately, eradicating HIV. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-125.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 346749 Full Announcement-PAR-23-125 -> PAR-23-125-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or before January 24, 2025 | PKG00280455 | Jul 15, 2023 | Jan 24, 2025 | View | |
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289364 | Dec 03, 2024 | Aug 15, 2025 | View |
Package 1
Mandatory forms
346749 RR_SF424_5_0-5.0.pdf
346749 PerformanceSite_4_0-4.0.pdf
346749 RR_OtherProjectInfo_1_4-1.4.pdf
346749 RR_KeyPersonExpanded_4_0-4.0.pdf
346749 PHS398_CoverPageSupplement_5_0-5.0.pdf
346749 PHS398_ResearchPlan_5_0-5.0.pdf
346749 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
346749 PHS_AssignmentRequestForm_4_0-4.0.pdf
346749 RR_Budget10_3_0-3.0.pdf
346749 RR_SubawardBudget10_30_3_0-3.0.pdf
346749 PHS398_ModularBudget_1_2-1.2.pdf
Package 2
Mandatory forms
346749 RR_SF424_5_0-5.0.pdf
346749 PerformanceSite_4_0-4.0.pdf
346749 RR_OtherProjectInfo_1_4-1.4.pdf
346749 RR_KeyPersonExpanded_4_0-4.0.pdf
346749 PHS398_CoverPageSupplement_5_0-5.0.pdf
346749 PHS398_ResearchPlan_5_0-5.0.pdf
346749 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
346749 PHS_AssignmentRequestForm_3_0-3.0.pdf
346749 RR_Budget10_3_0-3.0.pdf
346749 RR_SubawardBudget10_30_3_0-3.0.pdf
346749 PHS398_ModularBudget_1_2-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
